Type of the Paper (Article

Type of the Paper (Article

Supplementary figures and tables E g r 1 F g f2 F g f7 1 0 * 5 1 0 * * e e e * g g g * n n n * a a a 8 4 * 8 h h h * c c c d d d * l l l o o o * f f f * n n n o o o 6 3 6 i i i s s s s s s e e e r r r p p p x x x e e e 4 2 4 e e e n n n e e e g g g e e e v v v i i i t t t 2 1 2 a a a l l l e e e R R R 0 0 0 c o n tro l u n in fla m e d in fla m e d c o n tro l u n in fla m e d in fla m e d c o n tro l u n in fla m e d in fla m e d J a k 2 N o tc h 2 H if1 * 3 4 6 * * * e e e g g g n n n a a * * a * h h * h c c c 3 * d d * d l l l * o o o f f 2 f 4 n n n o o o i i i s s s s s s e e e r r 2 r p p p x x x e e e e e e n n n e e 1 e 2 g g g e e 1 e v v v i i i t t t a a a l l l e e e R R R 0 0 0 c o n tro l u n in fla m e d in fla m e d c o n tro l u n in fla m e d in fla m e d c o n tro l u n in fla m e d in fla m e d Z e b 2 C d h 1 S n a i1 * * 7 1 .5 4 * * e e e g g g 6 n n n * a a a * h h h c c c 3 * d d d l l l 5 o o o f f f 1 .0 * n n n * o o o i i i 4 * s s s s s s e e e r r r 2 p p p x x x 3 e e e e e e n n n e e e 0 .5 g g g 2 e e e 1 v v v i i i t t t a a a * l l l e e e 1 * R R R 0 0 .0 0 c o n tro l u n in fla m e d in fla m e d c o n tro l u n in fla m e d in fla m e d c o n tro l u n in fla m e d in fla m e d M m p 9 L o x V im 2 0 0 2 0 8 * * * e e e * g g g 1 5 0 * n n n * a a a * h h h * c c c 1 5 * 6 d d d l l l 1 0 0 o o o f f f n n n o o o i i i 5 0 s s s s s s * e e e r r r 1 0 4 3 0 p p p * x x x e e e * e e e n n n e e e 2 0 g g g e e e 5 2 v v v i i i t t t a a a l l l 1 0 e e e R R R 0 0 0 c o n tro l u n in fla m e d in fla m e d c o n tro l u n in fla m e d in fla m e d c o n tro l u n in fla m e d in fla m e d Supplementary Figure 1. Validation of RNA-Seq results by the comparison to our previous QPCR results related to epithelial-to-mesenchymal transition [13, 15]. The relative gene expression of Egr1, Fgf2, Fgf7, Jak2, Notch2, Hif1α, Zeb2, Cdh1, Snai1, Mmp9, Lox and Vim is shown from control (left columns), uninflamed (middle columns) and inflamed (right columns) rat colon sections. White and black columns represent RNA-Seq and previously published QPCR data, respectively. Data are presented as the mean ± SEM; *p < 0.05. 1 Supplementary table 1 List of significantly activated canonical pathways in the in vivo rat model of IBD based on p-value, calculated by Ingenuity Pathway Analysis (IPA) application. The abbreviations “UI—C,” “I—C” and “I—UI” represent the TNBS treated—uninflamed vs. control, TNBS-treated—inflamed vs. control and TNBS treated—inflamed vs. TNBS treated—uninflamed comparisons. 2 Supplementary Table 2. List of significantly activated canonical pathways in the in vivo rat model of IBD based on z-score, calculated by IPA application. Abbreviations as “UI—C,” “I—C” and “I—UI” represent the TNBS treated—uninflamed vs. control, TNBS-treated—inflamed vs. control and TNBS treated—inflamed vs. TNBS treated—uninflamed comparisons. 3 Supplementary Figure 2. Expression pattern of NOD-like receptors in experimentally induced colitis. Heat map shows gene expression alteration of NLR receptors between control, TNBS- treated uninflamed and TNBS-treated inflamed rat colon samples, where red marks elevation, while blue marks decrease by at least two-fold in expression level; false discovery rate (FDR) < 0.05. Bar plots show the expression alteration of Nod2, Nlrp3, Nlrp6 and Nlrc4 between rat sample groups; white and black columns represent RNA-Seq and QPCR data, respectively, *p < 0.05. Abbreviations as “UI—C,” “I—C” and “I—UI” represent the TNBS treated—uninflamed vs. control, TNBS-treated—inflamed vs. control and TNBS treated—inflamed vs. TNBS treated—uninflamed comparisons. 4 F u t1 F u t2 * 1 .5 4 * * e e * g g n n a a * h h c c 3 d d l l o o f 1 .0 f n n o o i i s s s s e e r r 2 p p x x e e e e n n e 0 .5 e g g e e 1 v v i i t t a a l * l e e * R * R 0 .0 0 c o n tro l u n in fla m e d in fla m e d c o n tro l u n in fla m e d in fla m e d F u t4 F u t9 * * 3 * 2 5 * e * e * g g n n a a 2 0 h h c c d d l l * o o f f 2 n n 1 5 o o i i s s s s e e r r 3 p p x x e e e e * n n e e 1 2 g g e e v v i i t t a a l l 1 e e R R 0 0 c o n tro l u n in fla m e d in fla m e d c o n tro l u n in fla m e d in fla m e d Supplementary Figure 3. Diverse expression pattern of FUTs at the site of colon inflammation in rat experimental colitis. The relative gene expression of Fut1, Fut2, Fut4 and Fut9 is shown from control (left columns), uninflamed (middle columns) and inflamed (right columns) rat colon sections. White and black columns represent RNA-Seq and QPCR data, respectively. Data are presented as the mean ± SEM; *p < 0.05. 5 Il1 Il6 Il1 0 4 0 0 2 0 1 2 0 * e e 3 5 0 e g g * g * n n n 1 0 0 a a a 3 0 0 h h * h * c c c 1 5 d d d l l l 2 5 0 o o o f f f 8 0 n n n 2 0 0 o o o i i i s s s s s s e e 1 5 0 e r r 1 0 r 6 0 3 0 * p p p * x x x e e e e e e * * n n n e e e 4 0 2 0 g g g * e e e 5 v v v i i i t t t a a a l l l 2 0 1 0 e e e R R R 0 0 0 c o n tro l u n in fla m e d in fla m e d c o n tro l u n in fla m e d in fla m e d c o n tro l u n in fla m e d in fla m e d C x c l1 T n f T n fa ip 6 5 0 8 * 1 0 * * * e e e * g g g * n n n * a a a 4 0 8 h h h * c c c * 6 d d d l l l * o o o f f f n n n o o o 3 0 6 * i i i s s s s s s e e e * r r r 4 p p p x x x e e e 2 0 4 e e e n n n e e e g g g e e e 2 v v v i i i t t t 1 0 2 a a a l l l e e e R R R 0 0 0 c o n tro l u n in fla m e d in fla m e d c o n tro l u n in fla m e d in fla m e d c o n tro l u n in fla m e d in fla m e d Supplementary Figure 4.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    10 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us